Distinct macrophage fates after in vitro infection with different species of Leishmania: Induction of apoptosis by Leishmania (Leishmania) amazonensis, but not by Leishmania (Viannia) guyanensis

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  DaMata, Jarina Pena ^a   Mendes, Bárbara Pinheiro ^a   Maciel Lima, Kátia ^a   Menezes, Cristiane Alves Silva ^a   Dutra, Walderez Ornelas ^a   Sousa, Lirlândia Pires ^a   Horta, Maria Fátima ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL FATE; CELL PHAGOCYTOSIS; CONTROLLED STUDY; DIPLOIDY; DNA CLEAVAGE; DNA FRAGMENTATION; ENZYME ACTIVATION; HOST PATHOGEN INTERACTION; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA AMAZONENSIS; LEISHMANIA GUYANENSIS; LEISHMANIASIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; DISEASE COURSE; DISEASE MODEL; IMMUNOLOGY; LEISHMANIA; METABOLISM; PARASITOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CASPASE 8; CASPASE 9; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; DIPLOIDY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA FRAGMENTATION; LEISHMANIA; LEISHMANIA GUYANENSIS; LEISHMANIASIS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 84949950866     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141196     Document Type: Article

References (60)

1. World Health Organization. Leishmaniasis: the disease and its epidemiology. 2014. Available: http://www.who.int/leishmaniasis/disease-epidemiology/en. Accessed January 2015.
2. Kedzierski L, Evans KJ. Immune response during cutaneous and visceral leishmaniasis. 2014. Parasitology 30: 1-19.
3. World Health Organization. Global Alert and Response. 2014. Available: http://www.who.int/csr/resources/publications/CSR-ISR-2000-1leish/en/. Accessed January 2015.
4. Gontijo B, de Carvalho ML. Leishmaniose Tegumentar Americana. Rev Soc Bras Med Trop 2003; 36:71-80. PMID: 12715066
5. Abreu-Silva AL, Calabrese KS, Cupolilo SMN, Cardoso FO, Souza CSF, Gonçalves da Costa SC. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected. Vet Parasitol 2004; 121: 179-187. PMID: 15135858
6. Silveira FT, Lainson R, de Castro Gomes CM, Laurenti MD, Corbett CEP. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Parasite Immunol 2009; 31: 423-431. doi: 10.1111/j.1365-3024.2009.01116.x PMID: 19646206
7. Dedet J-P. Cutaneous leishmaniasis in French Guiana: a review. Am J Trop.Med Hyg 1990; 43: 25-28. PMID: 2200289
8. Romero AS, Guerra MVF, Paes MG, Macedo VO. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: clinical findings and diagnostic approach. Clin Infect Dis 2001; 32:1304-12 PMID: 11303265
9. McMahon-Pratt D, Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 2004; 201: 206-224. PMID: 15361243
10. Sousa-Franco J, Araujo-Mendes E, Silva-Jardim I, Lima-Santos J, Faria DR, Dutra WO et al. Infectioninduced respiratory burst in BALB/c macrophages kills Leishmania guyanensis amastigotes through apoptosis: possible involvement in resistance to cutaneous leishmaniasis. Microb Infect 2006; 8: 390-400.
11. Soong L, Chang C-H, Sun J, Longley BJ Jr, Ruddle NH, Flavell RA et al. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J Immunol 1997; 158: 5374-5383. PMID: 9164958
12. Soong L. Subversion and utilization of host innate defense by Leishmania amazonensis. 2012 Frot Immunol 3:58
13. Ji J, Sun J, Qi H, Soong L. Analysis of T helper cell responses during infection with Leishmania amazonensis. Am J Trop Med Hyg 2002; 66: 338-345. PMID: 12164286
14. Ji J, Masterson J, Sun J, Soong L. CD4+Cd25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J Immunol 2005; 174: 7147-7153. PMID: 15905558
15. Ives A, Masina S, Castiglioni P, Prével F, Revaz-Breton M, Hartley M et al. MyD88 and TLR9 dependent immune responses mediate resistance to Leishmania guyanensis infections, irrespective of Leishmania RNA virus burden. PLoS ONE 2014; 9: e96766. doi: 10.1371/journal.pone.0096766 PMID: 24801628
16. Bourreau E, Prévot G, Pradinaud R, Launois P. Unresponsiveness of specific T cells to IL-12 is associated with active cutaneous leishmaniasis owing to Leishmania guyanensis. Scand J Immunol 2001; 54: 335-339. PMID: 11555399
17. Bourreau E, Ronet C, Darcissac E, Lise MC, Sainte Marie D, Clity E et al. Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leismania guyanensis. Infect Immun 2009; 77: 1465-1474. doi: 10.1128/IAI.01398-08 PMID: 19168733
18. Bourreau E, Prévot G, Pradinaud R, Launois P. Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12. J Infec Dis 2001; 183: 953-959.
19. Bourreau E, Ronet C, Couppié P, Sainte-Marie D, Tacchini-Cottier F, Launois P. IL-10 producing CD8+ T cells in human infection with Leishmania guyanensis. Microbes Infect 2007; 9: 1034-1041. PMID: 17544800
20. Dostálová A, Volf P. Leishmania development in sandflies: parasite-vector interaction overview. Parasit Vect 2012; 5:276
21. Bañuls AL, Hide M, Prugnolle F. Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv Parasitol 2007; 64:1-109. PMID: 17499100
22. WHO Expert Committee: Control of the Leishmaniases. Geneva, Switzerland: WHO Press, 2010.
23. Kaye P, Scott P. Leishmaniasis: complexity at the hostpathogen interface. Nat Rev Microbiol 2011; 9: 604-615. doi: 10.1038/nrmicro2608 PMID: 21747391
24. Bray RS, Alexander J. Leishmania and the macrophage. In: Peters W, Killick-Kendrich R, editors. The leishmaniasis in biology and medicine. Biology and epidemiology, vol. 1. London: Academic Press, 1987:211-33.
25. Wilson ME, Pearson RD. Immunology of leishmaniasis. In: Wyler DJ, editor. Modern parasite biology. New York: Freeman, 1990; 200-221.
26. Liew FY, O'Donnel CA. Immunology of leishmaniasis. Adv Parasitol 1993; 32:161-259. PMID: 8237615
27. Handman E. Cell biology of Leishmania. Adv Parasitol 1999; 44:1-39. PMID: 10563394
28. Rittig MG, Bogdan C. Leishmania-host cell interaction: complexities and alternative views. Parasitol Today 2000; 6: 292-297.
29. Noronha FS, Cruz JS, Beirão PS, Horta MF. Macrophage damage by Leishmania amazonensis cytolysin: evidence of pore formation on cell membrane. Infect Immun 2000; 68:4578-4584. PMID: 10899858
30. Almeida-Campos FR, Noronha FSM, Horta MF. The multitalented pore-forming proteins of intracellular pathogens. Microb Infect 2002; 4: 741-750.
31. Laskay T, van Zandbergen G, Solbach W. Neutrophil granulocytes - Trojan horses for Leishmania major and other intracellular microbes? Trends Microbiol 2003; 11: 210-214. PMID: 12781523
32. Aga E, Katschinsk DM, van Zandbergen G, Laufs H, Hansen B, Müller K et al. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J Immunol 2002; 169: 898-905. PMID: 12097394
33. van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, SolbachWet al. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol 2004; 173: 6521-6525. PMID: 15557140
34. Real F, Florentino PT, Reis LC, Ramos-Sanchez EM, Veras PS, Goto H et al. Cell-to-cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP-rich parasitophorous extrusions. Cell Microbiol 2014; 16: 1549-1564. doi: 10.1111/cmi.12311 PMID: 24824158
35. Santos JL, Andrade AA, Dias AAM, Bonjardim CA, Reis LF, Teixeira SMR et al. Differential sensitivity of C57BL/6 (M-1) and BALB/c (M-2) macrophages to IFN-γ/LPS for the production of NO: correlation with iNOS mRNA and protein expression. J Interferon Cytokine Res 2006; 26: 682-688. PMID: 16978073
36. Catelas I, Petit A, Vali H, Fragiskatos C, Meilleur R, Zukor DJ et al. Quantitative analysis of macrophage apoptosis vs. necrosis induced by cobalt and chromium ions in vitro. Biomaterials 2005; 26: 2441-2453 PMID: 15585247
37. Riccardi C, Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 2006; 1: 1458-1461. PMID: 17406435
38. Sousa LP, Silva BM, Brasil BS, Nogueira SV, Ferreira PC, Kroon EG et al. Plasminogen/plasmin regulates alpha-enolase expression through the MEK/ERK pathway. Biochem Biophys Res Comm 2005; 337: 1065-1071. PMID: 16225843
39. Gueirard P, Laplante A, Rondeau C, Milon G, Desjardins M. Trafficking of Leishmania donovani promastigotes in non-lytic compartments in neutrophils enable the subsequent transfer of parasites to macrophages. Cell Microbiol 2008; 10: 100-111. PMID: 17651446
40. Probst CM, Silva RA, Menezes JPB, Almeida TF, Gomes IN, Dallabona AC et al. A comparison of two disctinct murine macrophage gene expression profiles in response to Leishmania amazonensis infection. BMC Microbiology 2012; 12:22. doi: 10.1186/1471-2180-12-22 PMID: 22321871
41. Getti GT, Cheke RA, Rumber DP. Induction of apoptosis in host cells: a survival mechanism for Leishmania parasites? Parasitology 2008 135: 1391-1399. doi: 10.1017/S0031182008004915 PMID: 18775094
42. Deschacht M, Van Assche T, Hendrickx S, Bult H, Maes L, Cos P. Role of oxidative stress and apoptosis in the cellular response of murine macrophages upon Leishmania infection. Parasitology 2012; 139: 1429-1437. doi: 10.1017/S003118201200073X PMID: 22776404
43. Verçosa BL, Melo MN, Puerto HL, Mendonça IL, Vasconcelos AC. Apoptosis, inflammatory response and parasite load in skin of Leishmania (Leishmania) chagasi naturally infected dogs: a histomorphometric analysis. Vet Parasitol 2012; 189: 162-170. doi: 10.1016/j.vetpar.2012.04.035 PMID: 22694833
44. Widmer G, Comeau AM, Furlong DB, Wirth DF, Patterson JL. Characterization of a RNA virus from the parasite Leishmania. Proc Natl Acad Sci U.S.A. 1989; 86: 5979-5982. PMID: 2762308
45. Cullen SP, Martin SJ. Caspase activated pathways: some recent progress. Cell Death Differ 2009; 16: 935-938. doi: 10.1038/cdd.2009.59 PMID: 19528949
46. Maelfait J, Vercammen E, Janssens S, Schotte P, Haegman M, Magez S et al. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1 beta maturation by caspase-8. J Exp Med 2008; 205: 1967-1973. doi: 10.1084/jem.20071632 PMID: 18725521
47. Siegel RM. Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol 2006; 6: 308-317. PMID: 16557262
48. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; 9: 231-241. PMID: 18073771
49. Assis RR, Ibraim IC, Noronha FS, Turco SJ, Soares RP. Glycoinositolphospholipids from Leishmania braziliensis and L. infantun: modulation of innate immune system and variations in carbohydrate structure. PLoS Neg Trop Dis 2012; 6: e1543.
50. Ibraim IC, Assis RR, Pessoa NL, Campos MA, Melo MN, Turco SJ et al. Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages. Parasit Vectors 2013; 6: 54. doi: 10.1186/1756-3305-6-54 PMID: 23497381
51. Muhannad S, McGachy HA, Schroeder J, Neamatallah T, Bryant CE, Millington O et al. Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression. Mol Immunol 2011; 48: 1800-1808. doi: 10.1016/j.molimm.2011.05.013 PMID: 21664694
52. Ferreira KS, Kreutz C, Macnelly S, Neubert K, Haber A, Bogyo M et al. Caspase-3 feeds back on caspase-8, Bid and XIAP in type I Fas signaling in primary mouse hepatocytes. Apoptosis 2012; 17: 503-515. doi: 10.1007/s10495-011-0691-0 PMID: 22246639
53. van Zandbergen G, Bollinger A, Wenzel A, Kamhawi S, Voll R, Klinger M et al. Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc Natl Acad Sci USA 2006; 103: 13837-13842. PMID: 16945916
54. Wanderley JL, Pinto da Silva LH, Deolindo P, Soong L, Borges VM, Prates DB et al. Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of leishmaniasis. PLoS One 2009; 4: e5733 doi: 10.1371/journal.pone.0005733 PMID: 19478944
55. de Freitas Balanco JM, Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C et al. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr Biol 2001; 11: 1870-1873. PMID: 11728310
56. Barral-Netto M, Barral A, Brownell CE, Skeiky YA, Ellingsworth LR, Twardzik DR et al. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 1992; 257: 545-548. PMID: 1636092
57. Chatelain R, Mauze S, Coffman RL. Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunol 1999; 21: 211-218. PMID: 10320618
58. Ribeiro-Gomes FL, Otero AC, Gomes NA, Moniz-de-Souza MC, Cysne-Finkesltein L, Arnholdt AC et al. Macrophage interactions with neutrophils regulate Leishmania major infection. J Immunol 2004; 172: 4454-4462. PMID: 15034061
59. Afonso L, Borges VM, Cruz H, Ribeiro-Gomes FL, Dos Reis GA, Dutra AN et al. Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis. J Leukoc Biol 2008; 84: 389-396. doi: 10.1189/jlb.0108018 PMID: 18483206
60. Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol 2011; 41:1203-1217. doi: 10.1002/eji.201141550 PMID: 21523780